Literature DB >> 19423865

Sphingosine-1-phosphate: a novel nonhypoxic activator of hypoxia-inducible factor-1 in vascular cells.

Maude D Michaud1, Geneviève A Robitaille, Jean-Philippe Gratton, Darren E Richard.   

Abstract

OBJECTIVE: Sphingosine-1-phosphate (S1P) is a potent bioactive phospholipid responsible for a variety of vascular cell responses. Hypoxia-inducible factor-1 (HIF-1) is a transcriptional activator of genes essential for adaptation to low oxygen. S1P and HIF-1 are both important mediators of vascular cell responses such as migation, proliferation, and survival. Studies have shown that nonhypoxic stimuli can activate HIF-1 in oxygenated conditions. Here, we attempt to determine whether S1P can modulate the vascular activation of HIF-1. METHODS AND
RESULTS: We show that in vascular endothelial and smooth muscle cells, activation of the S1P type-2 receptor by S1P strongly increases HIF-1 alpha protein levels, the active subunit of HIF-1. This is achieved through pVHL-independent stabilization of HIF-1 alpha. We demonstrate that the HIF-1 nuclear complex, formed on S1P stimulation, is transcriptionally active and specifically binds to a hypoxia-responsive elements. Moreover, S1P activates the expression of genes known to be closely regulated by HIF-1.
CONCLUSIONS: Our results identify S1P as a novel and potent nonhypoxic activator of HIF-1. We believe that understanding the role played by HIF-1 in S1P gene regulation will have a strong impact on different aspects of vascular biology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19423865     DOI: 10.1161/ATVBAHA.109.185280

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  22 in total

1.  Differential modulation of S1PR(1-5) and specific activities of SphK and nSMase in pulmonary and cerebral tissues of rats exposed to hypobaric hypoxia.

Authors:  Sonam Chawla; Shweta Saxena
Journal:  Lipids       Date:  2014-11-16       Impact factor: 1.880

Review 2.  Novel pathways for implantation and establishment and maintenance of pregnancy in mammals.

Authors:  Fuller W Bazer; Guoyao Wu; Thomas E Spencer; Greg A Johnson; Robert C Burghardt; Kayla Bayless
Journal:  Mol Hum Reprod       Date:  2009-10-30       Impact factor: 4.025

Review 3.  Hypoxia-inducible factor signaling in pulmonary hypertension.

Authors:  Soni Savai Pullamsetti; Argen Mamazhakypov; Norbert Weissmann; Werner Seeger; Rajkumar Savai
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

4.  Hypoxia-inducible factor-1 activation in nonhypoxic conditions: the essential role of mitochondrial-derived reactive oxygen species.

Authors:  David A Patten; Véronique N Lafleur; Geneviève A Robitaille; Denise A Chan; Amato J Giaccia; Darren E Richard
Journal:  Mol Biol Cell       Date:  2010-07-21       Impact factor: 4.138

5.  Hsp90 as a gatekeeper of tumor angiogenesis: clinical promise and potential pitfalls.

Authors:  J E Bohonowych; U Gopal; J S Isaacs
Journal:  J Oncol       Date:  2010-06-24       Impact factor: 4.375

6.  Hypoxic preconditioning induces stroke tolerance in mice via a cascading HIF, sphingosine kinase, and CCL2 signaling pathway.

Authors:  Bradley K Wacker; Jennifer L Perfater; Jeffrey M Gidday
Journal:  J Neurochem       Date:  2012-11-01       Impact factor: 5.372

7.  Exogenous sphingosine 1-phosphate protects murine splenocytes against hypoxia-induced injury.

Authors:  Sonam Chawla; Chayanika Sahni; Rajkumar Tulsawani; Mrinalini Singh; Deepika Saraswat; Anju Bansal; Shweta Saxena
Journal:  Lipids       Date:  2013-11-05       Impact factor: 1.880

Review 8.  Bioactive lysolipids in cancer and angiogenesis.

Authors:  Yu Hisano; Timothy Hla
Journal:  Pharmacol Ther       Date:  2018-07-23       Impact factor: 12.310

9.  Sphingosine-1-Phosphate as a Regulator of Hypoxia-Induced Factor-1α in Thyroid Follicular Carcinoma Cells.

Authors:  Veronica Kalhori; Kati Kemppainen; Muhammad Yasir Asghar; Nina Bergelin; Panu Jaakkola; Kid Törnquist
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

10.  Fenretinide causes emphysema, which is prevented by sphingosine 1-phoshate.

Authors:  Masanori Yasuo; Shiro Mizuno; Jeremy Allegood; Donatas Kraskauskas; Harm J Bogaard; Sarah Spiegel; Norbert F Voelkel
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.